In October 2022, Pfizer and the Excellence in Pediatrics Institute (EIP) surveyed EIP’s network along with relevant civic, advocacy, and HCP organisations across Europe to uncover barriers and identify solutions to making routine pediatric immunisation a priority. The quantitative, closed-ended questionnaire focused on routine pediatric immunisations in Europe, with COVID-19 vaccinations excluded from the survey. The survey received 106 valid and completed responses between October 6-21.

Survey Results Presentation: Full Details

Explore the detailed findings from the survey conducted by Excellence in Pediatrics Institute, with support from Pfizer.
EIP Stakeholder Survey Results

Infographic: Key Results

See the top-line findings on the challenges and potential solutions to encouraging routine pediatric vaccination in Europe among parents and healthcare providers.


Article: Context, Findings & Expert Commentary

Learn more about recent trends leading to lower pediatric vaccination uptake in Europe and how the survey findings can be applied to encourage vaccination prioritisation, along with expert perspectives from Excellence in Pediatrics Institute and Pfizer.